Gert Baas

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.

Older people’s attitudes towards deprescribing cardiometabolic medication

K. Taxis, J. Hugtenburg, P. Denig, 2021, BMC Geriatrics.

Barriers and Enablers of Older Patients to Deprescribing of Cardiometabolic Medication: A Focus Group Study

K. Taxis, M. Bouvy, J. Hugtenburg, 2020, Frontiers in Pharmacology.

Pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among people with type 2 diabetes.

K. Taxis, P. Denig, M. Heringa, 2022, Research in social & administrative pharmacy : RSAP.